• About
  • News
  • Events
  • Media Kit
  • Advertise
  • Subscribe
  • Contact Us
  • Online Magazine
  • Newsletter
  • TürkçeTürkçe
No Result
View All Result
Food Turkey
No Result
View All Result
Food Turkey
No Result
View All Result
Danone invests €50 million in Polish production facility to expand medical nutrition capabilities

Danone invests €50 million in Polish production facility to expand medical nutrition capabilities

editor by editor
14/09/2023
in Company News, Sector News
1 min read

Danone announces a €50 million line expansion of its Opole, Poland, production facility, to expand its medical nutrition capabilities to serve patients across the world, as it targets further growth in the adult medical nutrition market.

The expansion comes as macro trends point to a growing demand for the category as populations continue to age and the rate of chronic diseases increases. Many people will require medical nutrition at some stage of their lives, with diseases such as cancer and strokes resulting in malnutrition of patients. Although medical nutrition is proven to support patient outcomes, only one in three patients who could benefit from it currently receive it – showing that there is a growing need for medical nutrition solutions.

Specialized nutrition (which includes medical nutrition) accounts for 30% of Danone’s total revenues, with a growth of +10% like-for-like in 2022. This investment marks further progress against the Renew Danone strategy to drive growth within its categories, and notably in its medical nutrition activities where Danone aims at serving a growing number of patients.

Danone is already the market leader across Europe in adult medical nutrition. The Opole investment will allow Danone to expand its highly specialized production capabilities through a new medical nutrition production line which will serve patients who are dependent on feeding tubes as they cannot swallow or drink normally. Opole will be Danone’s second European plant to produce Danone’s enteral nutrition range Nutrison.

Tags: #chronicdiseases#danone#enternalnutrition#expansion#growth#healthcare#medicalnutrition#nutrison#nutritionalsolutions#poland#productionfacility#renewdanone#specializednutritioninvestment
Previous Post

FERM FOOD presents Binders: Multifunctional and Fermented whole grain ingredients for food

Next Post

The global artificial sweetener market is projected to grow by USD 2.01 billion from 2022 to 2027

editor

editor

Related Posts

What to expect in chocolate in 2024 – and beyond
Company News

What to expect in chocolate in 2024 – and beyond

by fdturkey
01/12/2023
Bühler’s Flavor Creation Center is operating at full power for customers
Company News

Bühler’s Flavor Creation Center is operating at full power for customers

by fdturkey
30/11/2023
Chocolate at its best: Gudrun launches revolutionary treat based on upcycling
Company News

Chocolate at its best: Gudrun launches revolutionary treat based on upcycling

by fdturkey
30/11/2023
FiE 2023: Loryma welcomes you home
Company News

FiE 2023: Loryma welcomes you home

by fdturkey
29/11/2023
Nestlé develops N3 milk with new nutritional benefits, launches first in China
Company News

Nestlé develops N3 milk with new nutritional benefits, launches first in China

by fdturkey
29/11/2023
Next Post
The global artificial sweetener market is projected to grow by USD 2.01 billion from 2022 to 2027

The global artificial sweetener market is projected to grow by USD 2.01 billion from 2022 to 2027

“Milling Industry Award of the Year” for Cenk Engin of Stern Ingredients Turkey

"Milling Industry Award of the Year" for Cenk Engin of Stern Ingredients Turkey

Steakholder Foods files provisional patent for immortal bovine cell line in cultivated meat production

Steakholder Foods files provisional patent for immortal bovine cell line in cultivated meat production

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

ONLINE MAGAZINE

The Latest Video News

  • About
  • News
  • Events
  • Media Kit
  • Advertise
  • Subscribe
  • Contact Us
  • Online Magazine
  • Newsletter
Call us: +90 212 454 22 22

© Copyright 2023, All Rights Reserved

No Result
View All Result
  • About
  • News
  • Events
  • Media Kit
  • Advertise
  • Subscribe
  • Contact Us
  • Online Magazine
  • Newsletter

© Copyright 2023, All Rights Reserved